Cisbio Bioassays - Articles and news items

Drug Targets Supplement 2012

Drug Targets: In-depth focus 2012

Drug Targets, Issue 6 2012, Supplements / 11 December 2012 / Patricia McDonald / Emmanuel Sturchler / Dayue Darrel Duan

GPCR allosteric modulation: new opportunities and challenges for drug discovery.
Chloride channels and cardiac arrhythmia: novel therapeutic targets?

Cisbio Bioassays Logo
Cisbio Bioassays Logo

Cisbio Bioassays launches epigenetics toolbox

News, Supplier news / 25 September 2012 / Cisbio Bioassays

Cisbio Bioassays announces the launch of its epigenetics toolbox for use in drug discovery research…

Cisbio Bioassays Logo

Cisbio Bioassays adds three cellular kinase assays to its kinase screening platform

News, Supplier news / 10 May 2012 / Ballou PR

Company combines expertise in assay design with its powerful HTRF® technology…

Cisbio Bioassays Introduces Tag-lite® Multi-Mode Cell Lines

Supplier news / 26 March 2010 /

Cisbio Bioassays (, a member of IBA group and global developer of HTRF® (Homogeneous Time-Resolved Fluorescence) technology and services used in assay development and drug screening, announced that it has introduced six multi-mode cell lines to its expanding Tag-lite® cellular platform…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...